Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Cost-per-responder analysis comparing romiplostim to rituximab in the treatment ...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain
Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España
M. Fernanda Lópeza, María Eva Mingotb, David Valcárcelc, Vicente Vicente Garcíad, Allison Perrine, Ignasi Campos Tapiasf,
Corresponding author
ignasic@amgen.com

Corresponding author.
a Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain
b Hospital Regional Universitario Carlos Haya, Málaga, Spain
c Hospital Vall d’Hebron, Barcelona, Spain
d Hospital Universitario Morales Meseguer, Murcia, Spain
e LA-SER Analytica, Nueva York, United States
f Global Health Economics, Amgen (Europe) GmbH, Zug, Switzerland
Read
72
Times
was read the article
13
Total PDF
59
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2023 March 3 2 5
2017 October 4 1 5
2017 September 8 2 10
2017 August 11 1 12
2017 July 11 4 15
2017 June 10 2 12
2017 May 12 1 13

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos